Basal Insulin Switch Starting Dose (FDA Labels)
The starting dose when one basal insulin replaces another, from the label of the insulin being started.
Open the tool → Runs in your browser. Data leaves only if you deliberately send a problem report from the interactive tool.
Example
- Basal insulin being started
- Lantus (insulin glargine 100 units/mL)
- Basal insulin being stopped
- NPH insulin
- Current basal insulin taken once or twice daily
- Twice daily
- Current total daily basal dose
- 50 units
Result: The Lantus label starts at 80% of the total: 40 units once daily, from 50 units a day of NPH insulin.
The tool opens with these values already filled in. Replace them with your own.
What you enter
- Basal insulin being started
- Basal insulin being stopped
- Current basal insulin taken once or twice daily
- Current total daily basal dose
- Adult or pediatric (Tresiba)
How this is calculated
Citation
FDA labels on DailyMed, section 2.4 of each: Lantus (switching to Lantus from other insulin therapies), Basaglar (changing to Basaglar), Toujeo (starting dose in patients already on insulin therapy) and Tresiba (switching to Tresiba). Read the sources: Lantus label ↗, Basaglar label ↗, Toujeo label ↗, Tresiba label ↗
A reference and educational tool. Not medical, legal, or financial advice, and not a substitute for clinician judgment.